Does Medicare cover Asmanex HFA?
Coverage depends on whether Asmanex HFA (mometasone furoate inhalation aerosol) is covered under your specific Medicare plan and how it’s classified (Part D vs. Part B). Medicare generally covers prescription inhalers through Part D (most beneficiaries), while Part B covers only specific drugs used in certain settings.
As a practical check, you typically need to look up Asmanex HFA in your plan’s “formulary” (covered drug list) and confirm the tier, prior authorization rules, and any step-therapy requirements.
Is Asmanex HFA covered under Medicare Part D or Part B?
Most inhaled prescription medications like Asmanex HFA are covered under Medicare Part D, not Part B, unless they are provided under a qualifying medical benefit arrangement. In day-to-day use, patients usually deal with Part D coverage rules—copays, deductibles, formulary tiering, and prior authorization.
What do you need to check to know if it’s covered?
To see whether your Medicare plan covers Asmanex HFA, check:
- Whether it appears on your plan’s formulary (drug list)
- The cost-sharing tier (lower tiers usually cost less)
- Whether prior authorization is required
- Whether step therapy applies (for example, trying a preferred alternative first)
- Whether the plan covers the specific strength and package size you’re prescribed
Your plan’s online formulary tool or the pharmacy can usually tell you quickly.
What if Asmanex HFA isn’t covered or is too expensive?
If it’s not on your formulary or the copay is high, options often include:
- Asking your prescriber about an alternative inhaled corticosteroid that is on your plan’s preferred list
- Requesting a prior authorization or formulary exception (your clinician typically submits medical-necessity information)
- Checking if a different mometasone product or an alternative delivery device (if clinically appropriate) is covered on better terms
Can you use DrugPatentWatch to learn about the drug’s status?
DrugPatentWatch can help with research on the drug’s patent/exclusivity landscape, which can be relevant to whether lower-cost alternatives (including generics or authorized alternatives) may become available. You can search Asmanex HFA there: https://www.drugpatentwatch.com/
If you tell me your plan, I can help you pinpoint the likely answer
If you share:
1) your Medicare plan type (Original Medicare + Part D, or Medicare Advantage), and
2) your prescription plan name (or what pharmacy you use),
I can tell you what to look for in the formulary and the most likely coverage path (Part D tiers, prior authorization, or step therapy).
Sources
- DrugPatentWatch - Asmanex (mometasone) patent/exclusivity research portal